BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$1.09B |
| 2 |
Tesla
TSLA
|
+$488M |
| 3 |
AbbVie
ABBV
|
+$312M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$271M |
| 5 |
Abbott
ABT
|
+$253M |
Top Sells
| 1 |
Invesco QQQ Trust
QQQ
|
+$642M |
| 2 |
Apple
AAPL
|
+$610M |
| 3 |
Visa
V
|
+$487M |
| 4 |
iShares MSCI ACWI ETF
ACWI
|
+$441M |
| 5 |
Technology Select Sector SPDR Fund
XLK
|
+$252M |
Sector Composition
| 1 | Technology | 18.06% |
| 2 | Financials | 12.01% |
| 3 | Consumer Discretionary | 9.98% |
| 4 | Healthcare | 8.94% |
| 5 | Communication Services | 6.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2301
PTC Therapeutics
PTCT
$4.85B
| $110K | ﹤0.01% |
2,591
-5,312
| -67% | -$225K |
|
2302
Barnes & Noble Education
BNED
$277M
| $109K | ﹤0.01% |
151
+93
| +160% | +$67K |
|
2303
Future Fuel
FF
$169M
| $108K | ﹤0.01% |
11,267
-2,723
| -19% | -$26.1K |
|
|
ITCI
2304
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $108K | ﹤0.01% |
2,648
-17,668
| -87% | -$721K |
|
2305
ArcelorMittal
MT
$26.4B
| $107K | ﹤0.01% |
+3,438
| New | +$107K |
|
2306
Eldorado Gold
EGO
$5.7B
| $106K | ﹤0.01% |
10,672
-1,948
| -15% | -$19.4K |
|
|
MRTX
2307
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $105K | ﹤0.01% |
651
-4,896
| -88% | -$791K |
|
2308
Horizon Bancorp
HBNC
$833M
| $105K | ﹤0.01% |
6,031
-14,467
| -71% | -$252K |
|
2309
Univest Financial
UVSP
$886M
| $105K | ﹤0.01% |
3,981
-8,775
| -69% | -$231K |
|
2310
Rhythm Pharmaceuticals
RYTM
$6.39B
| $104K | ﹤0.01% |
5,297
-9,437
| -64% | -$185K |
|
|
RADA
2311
DELISTED
Rada Electronic Industries Ltd
RADA
| $103K | ﹤0.01% |
8,464
| – | – |
|
|
TBIO
2312
DELISTED
Translate Bio, Inc. Common Stock
TBIO
| $103K | ﹤0.01% |
3,738
-10,404
| -74% | -$287K |
|
2313
Elbit Systems
ESLT
$23.6B
| $103K | ﹤0.01% |
790
| – | – |
|
2314
Microvision
MVIS
$343M
| $102K | ﹤0.01% |
+6,099
| New | +$102K |
|
2315
Cass Information Systems
CASS
$565M
| $102K | ﹤0.01% |
2,491
-120
| -5% | -$4.89K |
|
|
NWLI
2316
DELISTED
National Western Life Group, Inc. Class A
NWLI
| $101K | ﹤0.01% |
452
-831
| -65% | -$186K |
|
2317
QCR Holdings
QCRH
$1.3B
| $101K | ﹤0.01% |
2,098
-4,412
| -68% | -$212K |
|
2318
POSCO
PKX
$15.3B
| $101K | ﹤0.01% |
1,312
-371
| -22% | -$28.5K |
|
2319
Camden National
CAC
$684M
| $101K | ﹤0.01% |
2,106
-4,490
| -68% | -$214K |
|
2320
Argan
AGX
$3.18B
| $100K | ﹤0.01% |
2,097
-4,921
| -70% | -$235K |
|
2321
Stock Yards Bancorp
SYBT
$2.27B
| $100K | ﹤0.01% |
1,968
-6,108
| -76% | -$311K |
|
2322
HSBC
HSBC
$238B
| $100K | ﹤0.01% |
3,471
+2,110
| +155% | +$60.9K |
|
2323
Modine Manufacturing
MOD
$7.86B
| $99.9K | ﹤0.01% |
6,023
-17,549
| -74% | -$291K |
|
2324
Vishay Precision Group
VPG
$416M
| $99.4K | ﹤0.01% |
2,920
-2,780
| -49% | -$94.6K |
|
2325
Veracyte
VCYT
$2.43B
| $99K | ﹤0.01% |
2,475
-5,690
| -70% | -$227K |
|